Position in NAGE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,179
-$6,987 QoQ
Shares Held
13,873
+29.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NAGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MAI Capital Management holds $16,740,876 across 273 Biotechnology names. NAGE ranks #35 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,357 | $4,911,672 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,218 | $990,425 | |
| 3 | DNLI |
Denali Therapeutics Inc.
|
46,590 | $894,528 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
3,932 | $785,023 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
65,125 | $776,941 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
72,843 | $558,705 | |
| 7 | BCAB |
BioAtla, Inc.
|
51,504 | $414,607 | |
| 8 | RPRX |
Royalty Pharma plc
|
8,477 | $406,641 |
All Filings in NAGE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,179 | 13,873 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $68,166 | 10,718 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $99,523 | 10,667 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $153,711 | 10,667 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $73,602 | 10,667 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $56,641 | 10,667 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $38,934 | 10,667 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $32,899 | 12,051 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $37,121 | 10,667 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $15,253 | 10,667 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $15,573 | 10,667 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,747 | 10,667 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $16,320 | 10,667 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $17,920 | 10,667 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $13,120 | 10,667 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $17,813 | 10,667 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $26,240 | 10,667 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $39,894 | 10,667 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $66,882 | 10,667 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $105,176 | 10,667 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $99,629 | 10,667 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $51,201 | 10,667 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $42,774 | 10,667 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $48,961 | 10,667 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $34,774 | 10,667 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||